An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.
Clinical trial NCT04922021 · COMPLETED
Trial details
- NCT number
- NCT04922021
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2022-06-02
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.